Vaccine Adjuvants & Model Proteins

The contract issued by Iowa State University of Science and Technology seeks to establish a multi-year agreement for the procurement of discounted Vaccine Adjuvants and Model Proteins specifically for the Nanovaccine Institute. These products will be ordered on an as-needed basis, with quantities and product types varying according to the research requirements of the Institute. The solicitation, identified as RFQ-1001134, was posted on October 10, 2024, with a response deadline set for October 24, 2024. Bidders are required to submit responses exclusively through the ISUBid online portal and are encouraged to review all solicitation materials carefully, including instructions for proposal submission, inquiry procedures, and evaluation criteria. The contract size is estimated to range between 500,000 and 2,000,000 dollars, and the primary point of contact for inquiries is Jennifer Rogers via email or phone. The contractual framework incorporates comprehensive federal grant compliance provisions, as outlined in the university’s federal grant terms, which include mandatory clauses related to equal employment opportunity, wage requirements under the Davis-Bacon Act, rights to inventions, environmental regulations, debarment and suspension rules, anti-lobbying certifications, and procurement of recycled materials. These federal clauses are non-negotiable and must be incorporated into all applicable subcontracts. Additionally, the university’s general terms and conditions govern aspects such as delivery, acceptance, warranties, payment procedures, confidentiality, and legal obligations, ensuring a standardized contractual relationship. The procurement process emphasizes transparency, adherence to university policies, and compliance with applicable laws, with detailed instructions provided for proposal preparation, submission, and evaluation to facilitate a fair and efficient selection process.